Key result
Transcatheter and hybrid valve options emerge as feasible alternatives for inoperable patients with mitral annular calcification.
Why the study?
Optimal management of severe mitral valve disease due to mitral annular calcification remains challenging with evolving therapeutic options.
This review highlights the evolving surgical and transcatheter options for managing severe mitral valve dysfunction due to mitral annular calcification, expanding treatment to previously inoperable patients.
Answers are grounded in this paper and cite their sources.
Transcatheter and hybrid options may expand eligibility in high-risk mitral annular calcification; leaves open need for prospective comparative trials.
PURPOSE OF REVIEW: The aim of the article is to discuss different therapeutic options for patients with severe mitral valve dysfunction because of mitral annular calcification (MAC), including mitral valve repair, conventional mitral valve replacement, percutaneous transcatheter mitral valve replacement (TMVR), and hybrid procedures. RECENT FINDINGS: Optimal management of severe mitral valve disease because of MAC remains challenging. Various 'resect' or 'respect' repair strategies have been standardized and are applicable in eligible patients. Mitral valve replacement with a standard surgical bioprosthesis is often possible in nonrepair candidates, especially with noncircumferential MAC. TMVR has evolved as a feasible option for anatomically and/or clinically prohibitive open-surgery cases, with the caveat of strict anatomic eligibility criteria. Hybrid TMVR provides the advantages of both open-surgery and TMVR and has emerged as a promising alternative in select patients. SUMMARY: Surgical management of MAC and severe mitral valve disease continues to evolve. The addition of transcatheter valve options may benefit many patients previously considered inoperable and are now candidates for intervention. This review will summarize state-of-the-art management options for patients with MAC.
No takes yet. Share an insight, caveat, or question.
El‐Eshmawi et al. (2019) conducted a review in Severe mitral valve dysfunction due to mitral annular calcification (MAC). Surgical management, TMVR, and hybrid procedures was evaluated. Surgical management of mitral annular calcification continues to evolve, with transcatheter and hybrid valve options emerging as feasible alternatives for patients previously considered inoperable.
Synapse has enriched 10 related papers. Consider them for comparative context: